Labcorp Accelerates Adoption of Decentralized Trials Through Alliance with Medable

LabCorp has announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials through an alliance with Medable. The Covance patient and site interface will be powered by Medable’s modular software platform, providing access to applications that will allow patients to participate in decentralized clinical trials. 

For more information, click here.